Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Laille

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|October 26, 2020
Azacitidine is removed effectively by hemodialysisA G E Beer, E Laille, H Neuwirt, et al.
Leukemia|October 8, 2015
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromesG Garcia-Manero, S D Gore, S Kambhampati, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|October 26, 2020
Azacitidine is removed effectively by hemodialysisA G E Beer, E Laille, H Neuwirt, et al.
Leukemia|October 8, 2015
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromesG Garcia-Manero, S D Gore, S Kambhampati, et al.
Pageof 1